BASF acquires Verenium, a San Diego-based enzyme supplier.
BASF Acquires Enzyme Company 10-16-2013 BASF Corp. (Los Angeles) has acquired enzyme specialist Verenium (San Diego) to the tune of $62 million. The acquisition is expected to strengthen BASF’s position in the growing global enzyme market.
BASF purchased shares in Verenium at $4 each, an estimated 56% premium over the average share price recorded six months prior to the transaction. The transaction is expected to close once BASF can secure a majority of the remaining outstanding shares. In 2012, Verenium made $57 in revenue.
The Nutritional Outlook Podcast Episode 39: Nutritional Outlook's Ingredients to Watch in 2025
February 25th 2025In this episode, Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2025.